Abbott | ABT - Selling And Administration Expenses


Abbott reported $4.27B in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Agilent USD 475M 10M Jun/2026
AtriCure USD 82.88M 319K Sep/2026
Baxter International USD 730M 5M Sep/2026
Becton, Dickinson and Co. USD 1.26B 1000K Sep/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
Boston Scientific USD 1.68B 120M Sep/2026
Cooper Companies USD 401.3M 274.9M Jun/2026
Danaher USD 2.16B 87M Sep/2026
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 560.9M 300K Sep/2026
Globus Medical USD 288.47M 1.65M Sep/2026
Insulet USD 350.7M 5.9M Sep/2026
Integra LifeSciences USD 161.02M 5.2M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
J&J USD 6.25B 168M Sep/2026
Medtronic 3.2B 141M Jun/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Pfizer USD 3.28B 132M Sep/2026
Smith & Nephew USD 1.45B 29M Jun/2026
Solventum Corp USD 813M 114M Sep/2026
Stryker USD 2.12B 32M Jun/2026
Tandem Diabetes Care USD 113.94M 2.3M Sep/2026
Teleflex USD 220.72M 7.21M Sep/2026
Terumo JPY 109.58B 120M Sep/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Zimmer Biomet Holdings USD 855M 56.6M Sep/2026